+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV



Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV



Pediatric Infectious Disease Journal 35(1): E12-E18



Limited empirical investigation exists into longitudinal changes in cognition, behavior or quality of life (QOL) in children with perinatal HIV who are prescribed stimulants. This study was an analysis of longitudinal data from children age 3-19 years, with perinatal HIV infection, with and without prescriptions for stimulant medications [prescription (PG) and comparison (CG) groups, respectively], matched on age, availability of CD4% and outcome measures of cognition, behavior and QOL. Generalized estimating equation models were used to evaluate effects of stimulant exposure on change in measured outcomes over 3 years of follow-up, adjusting for baseline levels of outcomes and relevant covariates. Children in both the PG (n = 132) and the CG (n = 392) obtained mean verbal and performance (nonverbal) intelligence quotients (VIQ and PIQ, respectively) in the low-average range for age. At baseline, those in PG demonstrated more frequent signs of hyperactivity, impulsivity and conduct and learning problems than those in CG (P ≤ 0.003 in unadjusted analyses). At follow-up, after adjustment for baseline functioning and other relevant covariates, there were no significant changes from baseline in VIQ or PIQ. Stimulant prescription use, however, was associated with worsening symptoms of hyperactivity (P = 0.01), impulsivity (P = 0.04), learning problems (P < 0.001) and worsening of perceived health status (P < 0.001). The results suggest expectations for behavioral improvement may not align well with long-term effects of stimulant prescription use on behavior and QOL in children with HIV. Further research is necessary to determine if there are subsets of children who may benefit from stimulant therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 058905673

Download citation: RISBibTeXText

PMID: 26741589

DOI: 10.1097/INF.0000000000000947


Related references

Cardiac risk assessment before the use of stimulant medications in children and youth. Paediatrics & Child Health 14(9): 579-592, 2010

The Ugandan Youth Quality of Life index: assessing the relevance of incorporating perceived importance into the quality of life measure and factors associated with the quality of life among youth in slum areas of Kampala, Uganda. Global Health Action 9(): 31362-31362, 2016

Quality of life of mainstreamed hearing-impaired children--results of a study with the Inventory of Life Quality of Children and Youth (ILC). Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 38(3): 189-199, 2010

Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis. Pediatrics 136(6): 1144-1153, 2016

Optimism and pessimism in children with cancer and healthy children: confirmatory factor analysis of the youth life orientation test and relations with health-related quality of life. Journal of Pediatric Psychology 35(6): 672-682, 2010

Bacterial self-defense antibiotics release from organic-inorganic hybrid multilayer films for long-term anti-adhesion and biofilm inhibition properties. Nanoscale: -, 2017

Bacterial Seed Endophytes of Domesticated Cucurbits Antagonize Fungal and Oomycete Pathogens Including Powdery Mildew. Frontiers in Microbiology 9: 42-42, 2018

Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder. American Journal of Psychiatry 167(8): 977-986, 2010

Health-related quality of life in overweight German children and adolescents: do treatment-seeking youth have lower quality of life levels? Comparison of a clinical sample with the general population using a multilevel model approach. Bmc Public Health 13: 561-561, 2013

Negative life events: risk to health-related quality of life in children and youth with HIV infection. Journal of the Association of Nurses in Aids Care 18(1): 3-11, 2007

Cognition and quality of life in children with new-onset epilepsy. Epilepsy Currents 13(2): 85-87, 2013

Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics 126(4): E796-E806, 2010

A life needs model of pediatric service delivery: services to support community participation and quality of life for children and youth with disabilities. Physical & Occupational Therapy in Pediatrics 22(2): 53-77, 2002

Use of stimulant medications in children. American Family Physician 38(4): 197-202, 1988

Effect of anxiety on cognition, behavior, and stimulant response in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 28(6): 882-887, 1989